All these questions need to be answered in a world of limited resources. No pharma company, no matter what its size, has an infinite amount of money and resources to stream all its assets through its pipeline. For individual compounds under development, the challenge is to identify early assets that will fail so resources can be reallocated as quickly as possible. For an entire portfolio, whether it is for a specific therapeutic area or an entire company, managers need to understand how their decisions to invest in one product versus another affect risk and value.
The challenge is to answer all the necessary questions to gain the human and financial resources that keep a project moving forward as well as answer all the necessary constituencies. No one gets a perfect SAT score here. No one has the time and the staff to even list them all, let alone, answer them all.
To assist with these kinds of analyses that help understand the Opportunity, the Market and the Value, Manu Bammi and I have developed 10 Smart Questions that must be asked in order to truly understand opportunities from a 360 degree perspective.
Would you be interested in an article like this? If so, please write me at mrovner@smartanalyst.com